• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国心血管疾病的经济负担。

Economic burden of cardiovascular diseases in China.

机构信息

Lecturer of Health Economics, Department of Health Policy & Management, School of Public Health, Peking University Health Science Center, Beijing 100081, PR China.

出版信息

Expert Rev Pharmacoecon Outcomes Res. 2008 Aug;8(4):349-56. doi: 10.1586/14737167.8.4.349.

DOI:10.1586/14737167.8.4.349
PMID:20528342
Abstract

Cardiovascular diseases (CVD) have become the principle cause of death and disability among the middle-aged and elderly both in urban and rural areas of China. The objective of this study is to estimate the direct costs of CVD in China. Direct costs were estimated for the Chinese population with CVD in 2003 by sex, age, geography, type of medical condition and medical insurance, and then calculated based on the 2003 National Health Services Survey. The annual average direct medical cost and direct nonmedical cost were 4238.3 Yuan (US$529.8) and 153.9 Yuan (US$19.2) in urban areas, 2302.5 Yuan (US$278.1) and 416.4 Yuan (US$50.3) in rural areas, respectively. On average, only 23.9% of outpatient costs and 35.2% in-patient costs could be paid by various kinds of medical insurance. This disease burden led to 209.0 billion Yuan (US$26.1 billion) in direct costs in 2003. The strong positive association between CVD, and the economic burden to families and society, demonstrates the need for greater investment to prevent CVD in China.

摘要

心血管疾病(CVD)已成为中国城乡中老年人死亡和残疾的主要原因。本研究旨在估计中国 CVD 的直接成本。通过性别、年龄、地理位置、疾病类型和医疗保险,对 2003 年中国 CVD 人群的直接成本进行了估计,并根据 2003 年国家卫生服务调查进行了计算。城市地区 CVD 的年平均直接医疗费用和直接非医疗费用分别为 4238.3 元(529.8 美元)和 153.9 元(19.2 美元),农村地区分别为 2302.5 元(278.1 美元)和 416.4 元(50.3 美元)。平均而言,只有 23.9%的门诊费用和 35.2%的住院费用可以通过各种医疗保险支付。2003 年,这一疾病负担导致直接费用达到 2090 亿元(2610 亿美元)。CVD 与家庭和社会经济负担之间的强烈正相关关系表明,中国需要加大投入预防 CVD。

相似文献

1
Economic burden of cardiovascular diseases in China.中国心血管疾病的经济负担。
Expert Rev Pharmacoecon Outcomes Res. 2008 Aug;8(4):349-56. doi: 10.1586/14737167.8.4.349.
2
[Community-based study on disease burden of diarrhea in Zhejiang province].[浙江省腹泻疾病负担的社区研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Oct;30(10):1005-9.
3
[Analysis on direct economic burden of stroke in the rural population of Hanzhong, Shaanxi Province].[陕西省汉中市农村居民脑卒中直接经济负担分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Jul;26(7):494-7.
4
[Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China].[中国深圳乙肝相关疾病的经济负担及影响成本的因素]
Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Dec;31(12):1340-5.
5
[Economic burden of coronary heart disease and stroke attributable to hypertension in China].[中国高血压所致冠心病和脑卒中的经济负担]
Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Sep;27(9):744-7.
6
Economic burden of obesity-related chronic diseases in Mainland China.中国大陆肥胖相关慢性病的经济负担。
Obes Rev. 2008 Mar;9 Suppl 1:62-7. doi: 10.1111/j.1467-789X.2007.00440.x.
7
Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four cities.中国城市地区慢性阻塞性肺疾病的成本:四个城市的横断面研究
Int J Chron Obstruct Pulmon Dis. 2016 Oct 19;11:2625-2632. doi: 10.2147/COPD.S118523. eCollection 2016.
8
[Analysis on direct economic burden of community COPD patients and its influence factors in Chengdu].[成都社区慢性阻塞性肺疾病患者直接经济负担及其影响因素分析]
Wei Sheng Yan Jiu. 2007 Nov;36(6):706-10.
9
[Survey of economic burden of hepatitis B-related diseases in 12 areas in China].[中国12个地区乙肝相关疾病经济负担调查]
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Jul 10;38(7):868-876. doi: 10.3760/cma.j.issn.0254-6450.2017.07.005.
10
Economic costs of diabetes in the U.S. In 2007.2007年美国糖尿病的经济成本。
Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017.

引用本文的文献

1
The microeconomic impact of out-of-pocket medical expenditure on the households of cardiovascular disease patients in general and specialized heart hospitals in Ibadan, Nigeria.尼日利亚伊巴丹综合医院和专科医院心血管疾病患者家庭自付医疗支出的微观经济影响。
PLoS One. 2022 Jul 18;17(7):e0271568. doi: 10.1371/journal.pone.0271568. eCollection 2022.
2
Direct and Indirect Costs Associated with Coronary Artery (Heart) Disease in Tabriz, Iran.伊朗大不里士地区冠状动脉(心脏)病的直接和间接成本
Risk Manag Healthc Policy. 2020 Jul 31;13:969-978. doi: 10.2147/RMHP.S261612. eCollection 2020.
3
Comparison of multiple blood pressure frequency methods with optimum blood pressure measurement among Iranian individuals.
伊朗人群中多种血压测量频率方法与最佳血压测量的比较。
J Res Med Sci. 2020 Apr 13;25:40. doi: 10.4103/jrms.JRMS_129_19. eCollection 2020.
4
Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP).中国农村和城市成年人血脂异常的患病率及相关危险因素:来自中国国家卒中筛查与防治项目(CNSSPP)的结果。
BMC Public Health. 2019 Nov 11;19(1):1500. doi: 10.1186/s12889-019-7827-5.
5
Prevalence and patterns of multimorbidity among the elderly in China: a cross-sectional study using national survey data.中国老年人多病共存的患病率和模式:基于全国调查数据的横断面研究。
BMJ Open. 2019 Aug 18;9(8):e024268. doi: 10.1136/bmjopen-2018-024268.
6
Association of socioeconomic status with financial burden of disease among elderly patients with cardiovascular disease: evidence from the China Health and Retirement Longitudinal Survey.老年心血管疾病患者社会经济地位与疾病经济负担的关联:来自中国健康与养老追踪调查的证据
BMJ Open. 2018 Mar 22;8(3):e018703. doi: 10.1136/bmjopen-2017-018703.
7
Cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in China: a Markov model.中国成年人中添加钾的奶粉降低血压及预防心血管事件的成本效益:马尔可夫模型
BMJ Open. 2017 Sep 25;7(9):e017136. doi: 10.1136/bmjopen-2017-017136.
8
Cost and cost-effectiveness of a school-based education program to reduce salt intake in children and their families in China.在中国开展的一项旨在减少儿童及其家庭盐摄入量的校本教育项目的成本及成本效益。
PLoS One. 2017 Sep 13;12(9):e0183033. doi: 10.1371/journal.pone.0183033. eCollection 2017.
9
Prevalence, awareness, medication, control, and risk factors associated with hypertension in Bai ethnic group in rural China: the Yunnan Minority Eye Study.中国农村白族人群高血压的患病率、知晓率、治疗率、控制率及其相关危险因素:云南省少数民族眼病研究。
PLoS One. 2013 Aug 12;8(8):e70886. doi: 10.1371/journal.pone.0070886. eCollection 2013.
10
Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data.评估真实世界环境中植入式心脏复律除颤器治疗的结果:来自医院记录数据的结果。
BMC Health Serv Res. 2013 Mar 15;13:100. doi: 10.1186/1472-6963-13-100.